Literature DB >> 4840441

Entry of four tetracyclines into saliva and tears.

P D Hoeprich, D M Warshauer.   

Abstract

Although meningococci are susceptible to the tetracyclines by testing in vitro, oxytetracycline (OC) and doxycycline (DC) have failed to eliminate carriage, whereas minocycline (MC) has been effective. Because these congeners differ in lipophilicity, they and tetracycline (TC) were studied in volunteers by assay of serum, saliva, and tears obtained after 5 days of treatment. OC and TC were undetectable or attained concentrations subinhibitory for meningococci in saliva and tears. The concentrations of MC in saliva and tears were equal to or greater than the average minimal inhibitory concentration as long as 12 h post-dose. Near inhibitory concentrations resulted with DC at 100 mg/day; yet, doubling the dose to 100 mg/12 h did not yield concentrations that exceeded the average minimal inhibitory concentration for meningococci. The previous reports of failure or meager entry of DC and MC into saliva probably reflected extraction of these drugs in the paraffin chewed by subjects to stimulate salivary flow. The efficiency of entry of the tetracyclines into the secretions of the noninflamed upper respiratory tract correlates with lipophilicity at physiological pH, enabling prediction of meningococcal chemoprophylactic efficacy.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4840441      PMCID: PMC428969          DOI: 10.1128/AAC.5.3.330

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  54 in total

1.  Attempted prophylaxis against meningococcal infection using intramuscular penicillin.

Authors:  M S Artenstein; T H Lamson; J R Evans
Journal:  Mil Med       Date:  1967-12       Impact factor: 1.437

2.  Comparison of in vitro activity and clinical pharmacology of doxycycline with other tetracyclines.

Authors:  J E Rosenblatt; J E Barrett; J L Brodie; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

3.  Absorption and excretion of five tetracycline analogues in normal young men.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-05       Impact factor: 2.378

4.  Use of sulfonamide carbonic anhydrase inhibitors in treatment of meningococcal carriers: rationale and report of a clinical trial of ethoxzolamide.

Authors:  E Sanders
Journal:  Am J Med Sci       Date:  1967-11       Impact factor: 2.378

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

6.  Sulfonamide-resistant meningococcal disease.

Authors:  R C Singer
Journal:  Med Clin North Am       Date:  1967-05       Impact factor: 5.456

7.  Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci.

Authors:  J M Dowd; D Blink; C H Miller; P F Frank; W E Pierce
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

8.  Distribution and excretion of doxycycline in man.

Authors:  J Fabre; J S Pitton; J P Kunz
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

9.  Comparative serum binding of four tetracyclines under simulated in vivo conditions.

Authors:  J V Bennett; J S Mickelwait; J E Barrett; J L Brodie; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

10.  Metabolism and tissue distribution of radioisotopically labelled minocycline.

Authors:  R G Kelly; L A Kanegis
Journal:  Toxicol Appl Pharmacol       Date:  1967-07       Impact factor: 4.219

View more
  11 in total

Review 1.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 2.  The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Authors:  Gerd Geerling; Joseph Tauber; Christophe Baudouin; Eiki Goto; Yukihiro Matsumoto; Terrence O'Brien; Maurizio Rolando; Kazuo Tsubota; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 3.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

4.  A symposium on the tetracyclines: a major appraisal. Introduction.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1978-02

5.  Minocycline effects in patients with active trachoma.

Authors:  K F Tabbara; P Summanen; P B Taylor; E M Burd; O al Omar
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

Review 6.  Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD).

Authors:  Adam R Thode; Robert A Latkany
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

7.  Short term oral minocycline treatment of meibomianitis.

Authors:  J D Aronowicz; W E Shine; D Oral; J M Vargas; J P McCulley
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

8.  Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 9.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

Review 10.  A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.

Authors:  Tony K L Kiang; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.